Tumor-Induced Rickets in a Child With a Central Giant Cell Granuloma: A Case Report

被引:24
作者
Fernandez-Cooke, Elisa [1 ]
Cruz-Rojo, Jaime [1 ]
Gallego, Carmen [2 ]
Isabel Romance, Ana [3 ]
Mosqueda-Pena, Rocio [1 ]
Almaden, Yolanda [4 ,5 ]
Sanchez del Pozo, Jaime [1 ]
机构
[1] Hosp Univ 12 Octubre, Dept Pediat, Madrid 28041, Spain
[2] Hosp Univ 12 Octubre, Dept Radiol, Div Pediat, Madrid 28041, Spain
[3] Hosp Univ 12 Octubre, Dept Oral & Maxillofacial Surg, Div Pediat, Madrid 28041, Spain
[4] Univ Cordoba, Reina Sofia Univ Hospital, IMIBIC, Lipid & Atherosclerosis Unit, E-14071 Cordoba, Spain
[5] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr, Madrid, Spain
关键词
OF-THE-LITERATURE; ONCOGENIC OSTEOMALACIA; MESENCHYMAL TUMORS; FIBROBLAST-GROWTH-FACTOR-23; THERAPY; FGF23; LOCALIZATION; CINACALCET;
D O I
10.1542/peds.2014-2218
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Tumor-induced osteomalacia/rickets is a rare paraneoplastic disorder associated with a tumor-producing fibroblast growth factor 23 (FGF23). We present a child with symptoms of rickets as the first clinical sign of a central giant cell granuloma (CGCG) with high serum levels of FGF23, a hormone associated with decreased phosphate resorption. A 3-year-old boy presented with a limp and 6 months later with painless growth of the jaw. On examination gingival hypertrophy and genu varum were observed. Investigations revealed hypophosphatemia, normal 1,25 and 25 (OH) vitamin D, and high alkaline phosphatase. An MRI showed an osteolytic lesion of the maxilla. Radiographs revealed typical rachitic findings. Incisional biopsy of the tumor revealed a CGCG with mesenchymal matrix. The CGCG was initially treated with calcitonin, but the lesions continued to grow, making it necessary to perform tracheostomy and gastrostomy. One year after onset the hyperphosphaturia worsened, necessitating increasing oral phosphate supplements up to 100 mg/kg per day of elemental phosphorus. FGF23 levels were extremely high. Total removal of the tumor was impossible, and partial reduction was achieved after percutaneous computed tomography-guided radiofrequency, local instillation of triamcinolone, and oral propranolol. Compassionate use of cinacalcet was unsuccessful in preventing phosphaturia. The tumor slowly regressed after the third year of disease; phosphaturia improved, allowing the tapering of phosphate supplements, and FGF23 levels normalized. Tumor-induced osteomalacia/rickets is uncommon in children and is challenging for physicians to diagnose. It should be suspected in patients with intractable osteomalacia or rickets. A tumor should be ruled out if FGF23 levels are high.
引用
收藏
页码:E1518 / E1523
页数:6
相关论文
共 24 条
[1]   Propranolol vs Prednisolone for Symptomatic Proliferating Infantile Hemangiomas [J].
Bauman, Nancy M. ;
McCarter, Robert J. ;
Guzzetta, Philip C. ;
Shin, Jennifer J. ;
Oh, Albert K. ;
Preciado, Diego A. ;
He, Jianping ;
Greene, Elizabeth Anne ;
Puttgen, Katherine B. .
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2014, 140 (04) :323-330
[2]   68Ga DOTA-TATE PET/CT allows tumor localization in patients with tumor-induced osteomalacia but negative 111In-octreotide SPECT/CT [J].
Breer, Stefan ;
Brunkhorst, Thomas ;
Beil, F. Timo ;
Peldschus, Kersten ;
Heiland, Max ;
Klutmann, Susanne ;
Barvencik, Florian ;
Zustin, Jozef ;
Gratz, Klaus-Friedrich ;
Amling, Michael .
BONE, 2014, 64 :222-227
[3]   Fibroblast growth factor-23 is regulated by lα,25-dihydroxyvitamin D [J].
Collins, MT ;
Lindsay, JR ;
Jain, A ;
Kelly, MH ;
Cutler, CM ;
Weinstein, LS ;
Liu, J ;
Fedarko, NS ;
Winer, KK .
JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (11) :1944-1950
[4]   Regression of central giant cell granuloma by a combination of imatinib and interferon: a case report [J].
de Lang, Jan ;
van Rijn, Rick R. ;
van den Berg, Henk ;
van den Akker, Hans P. .
BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2009, 47 (01) :59-61
[5]   Central giant cell granuloma of the jaw: a review of the literature with emphasis on therapy options [J].
De lange, Jan ;
van den Akker, Hans P. ;
van den Berg, Henk .
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2007, 104 (05) :603-615
[6]   Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients - Proposal of diagnostic criteria using FGF23 measurement [J].
Endo, Itsuro ;
Fukumoto, Seiji ;
Ozono, Keiichi ;
Namba, Noriyuki ;
Tanaka, Hiroyuki ;
Inoue, Daisuke ;
Minagawa, Masanori ;
Sugimoto, Toshitsugu ;
Yamauchi, Mika ;
Michigami, Toshimi ;
Matsumoto, Toshio .
BONE, 2008, 42 (06) :1235-1239
[7]   Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity - An analysis of 32 cases and a comprehensive review of the literature [J].
Folpe, AL ;
Fanburg-Smith, JC ;
Billings, SD ;
Bisceglia, M ;
Bertoni, F ;
Cho, JY ;
Econs, MJ ;
Inwards, CY ;
de Beur, SMJ ;
Mentzel, T ;
Montgomery, E ;
Michal, M ;
Miettinen, M ;
Mills, SE ;
Reith, JD ;
O'Connell, JX ;
Rosenberg, AE ;
Rubin, BP ;
Sweet, DE ;
Vinh, TN ;
Wold, LE ;
Wehrli, BM ;
White, FKE ;
Zaino, RJ ;
Weiss, SW .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2004, 28 (01) :1-30
[8]   Anti-fibroblast growth factor 23 antibody therapy [J].
Fukumoto, Seiji .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2014, 23 (04) :346-351
[9]   Cinacalcet in the management of tumor-induced osteomalacia [J].
Geller, Jordan L. ;
Khosravi, Azarmindokht ;
Kelly, Marilyn H. ;
Riminucci, Mara ;
Adams, John S. ;
Collins, Michael T. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 (06) :931-937
[10]   Calcimimetic agents and secondary hyperparathyroidism: rationale for use and results from clinical trials [J].
Goodman, WG .
PEDIATRIC NEPHROLOGY, 2003, 18 (12) :1206-1210